Free Trial

Viking Therapeutics (VKTX) News Today

Viking Therapeutics logo
$27.18 +0.20 (+0.74%)
Closing price 05/27/2025 04:00 PM Eastern
Extended Trading
$27.24 +0.05 (+0.20%)
As of 04:04 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

VKTX Latest News

Viking Therapeutics, Inc. stock logo
Woodline Partners LP Raises Stock Position in Viking Therapeutics, Inc. (NASDAQ:VKTX)
Woodline Partners LP raised its stake in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 46.2% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 93,294 shares of the biotechnology compan
Viking Therapeutics, Inc. stock logo
Waverly Advisors LLC Increases Holdings in Viking Therapeutics, Inc. (NASDAQ:VKTX)
Waverly Advisors LLC raised its stake in Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 34.6% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 48,369 shares of the biotechnology company'
Viking Therapeutics, Inc. stock logo
Castleark Management LLC Trims Stock Position in Viking Therapeutics, Inc. (NASDAQ:VKTX)
Castleark Management LLC lessened its position in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 85.8% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 4,978 shares of the biotechnology company's stock aft
Viking Therapeutics, Inc. stock logo
Bank of America Corp DE Reduces Holdings in Viking Therapeutics, Inc. (NASDAQ:VKTX)
Bank of America Corp DE lowered its stake in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 14.5% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 361,551 shares of the biotechnology company's stock
Viking Therapeutics, Inc. stock logo
Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. Reduces Position in Viking Therapeutics, Inc. (NASDAQ:VKTX)
Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. reduced its holdings in Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 45.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 267,464 shares of the bio
Viking Therapeutics, Inc. stock logo
Tang Capital Management LLC Grows Stock Position in Viking Therapeutics, Inc. (NASDAQ:VKTX)
Tang Capital Management LLC lifted its stake in Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 166.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 320,000 shares of the biotechnology company's st
Viking Therapeutics, Inc. stock logo
Tema Etfs LLC Invests $813,000 in Viking Therapeutics, Inc. (NASDAQ:VKTX)
Tema Etfs LLC bought a new stake in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm bought 20,215 shares of the biotechnology company's stock, valued at approximately
Viking Therapeutics, Inc. stock logo
Raiffeisen Bank International AG Invests $477,000 in Viking Therapeutics, Inc. (NASDAQ:VKTX)
Raiffeisen Bank International AG bought a new position in Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor bought 12,000 shares of the biotechnology company's stock, valued at appro
Viking Therapeutics, Inc. stock logo
BNP Paribas Financial Markets Has $1.88 Million Stock Holdings in Viking Therapeutics, Inc. (NASDAQ:VKTX)
BNP Paribas Financial Markets lessened its holdings in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 46.1% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 46,701 shares of the biotechnology company's stock after selling 40,011 shares during
Viking Therapeutics, Inc. stock logo
Second Line Capital LLC Purchases 11,393 Shares of Viking Therapeutics, Inc. (NASDAQ:VKTX)
Second Line Capital LLC boosted its position in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 29.9% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 49,511 shares of the biotechnology company's st
Viking Therapeutics, Inc. stock logo
Rafferty Asset Management LLC Has $10.91 Million Stake in Viking Therapeutics, Inc. (NASDAQ:VKTX)
Rafferty Asset Management LLC boosted its holdings in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 6.9% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 271,163 shares of the biotechnology company
Viking Therapeutics, Inc. stock logo
Man Group plc Boosts Position in Viking Therapeutics, Inc. (NASDAQ:VKTX)
Man Group plc lifted its stake in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 3,373.4% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 448,732 shares of the biotechnology company's stock
Viking Therapeutics, Inc. stock logo
Sphera Funds Management LTD. Has $4.16 Million Holdings in Viking Therapeutics, Inc. (NASDAQ:VKTX)
Sphera Funds Management LTD. lowered its stake in Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 22.4% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 103,270 shares of the biotechnology company's stock after
Viking Therapeutics, Inc. stock logo
Northern Trust Corp Increases Stock Holdings in Viking Therapeutics, Inc. (NASDAQ:VKTX)
Northern Trust Corp increased its position in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 11.4% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 535,984 shares of the biotechnology company's
Viking Therapeutics, Inc. stock logo
Dimensional Fund Advisors LP Has $4.06 Million Holdings in Viking Therapeutics, Inc. (NASDAQ:VKTX)
Dimensional Fund Advisors LP lowered its position in Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 9.4% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 100,762 shares of the biotechnology company's stock after selling 10,394 shares dur
Viking Therapeutics, Inc. stock logo
Integral Health Asset Management LLC Sells 100,000 Shares of Viking Therapeutics, Inc. (NASDAQ:VKTX)
Integral Health Asset Management LLC reduced its stake in Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 40.0% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 150,000 shares of the biotechnology company
Viking Therapeutics, Inc. stock logo
Ensign Peak Advisors Inc Lowers Holdings in Viking Therapeutics, Inc. (NASDAQ:VKTX)
Ensign Peak Advisors Inc decreased its position in Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 8.7% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 412,656 shares of the b
Viking Therapeutics, Inc. stock logo
Ameriprise Financial Inc. Has $59.54 Million Stock Position in Viking Therapeutics, Inc. (NASDAQ:VKTX)
Ameriprise Financial Inc. increased its position in Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 228.5% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,479,596 shares of the biotechnology comp
Viking Therapeutics, Inc. stock logo
Viking Therapeutics, Inc. (NASDAQ:VKTX) Given Average Recommendation of "Buy" by Analysts
Shares of Viking Therapeutics, Inc. (NASDAQ:VKTX - Get Free Report) have received a consensus rating of "Buy" from the fourteen ratings firms that are presently covering the firm, Marketbeat.com reports. Two analysts have rated the stock with a hold rating, ten have assigned a buy rating and two h
Viking Therapeutics, Inc. stock logo
Granahan Investment Management LLC Has $12.30 Million Stock Holdings in Viking Therapeutics, Inc. (NASDAQ:VKTX)
Granahan Investment Management LLC trimmed its holdings in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 6.1% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 305,586 shares of the biotechnology company's stock after selling 19,701 shares
Viking Therapeutics, Inc. stock logo
FORA Capital LLC Makes New $1.12 Million Investment in Viking Therapeutics, Inc. (NASDAQ:VKTX)
FORA Capital LLC acquired a new stake in Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 27,744 shares of the biotechnology company's st
Viking Therapeutics, Inc. stock logo
Viking Therapeutics, Inc. (NASDAQ:VKTX) Shares Sold by Fred Alger Management LLC
Fred Alger Management LLC decreased its holdings in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 85.4% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 71,569 shares of the biotechnolog
Viking Therapeutics, Inc. stock logo
Hsbc Holdings PLC Sells 9,437 Shares of Viking Therapeutics, Inc. (NASDAQ:VKTX)
Hsbc Holdings PLC reduced its position in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 61.7% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 5,849 shares of the biotechnology company's stock after selling 9,43
3 Monster Stocks in the Making
Viking Therapeutics, Inc. stock logo
Frontier Capital Management Co. LLC Purchases 16,321 Shares of Viking Therapeutics, Inc. (NASDAQ:VKTX)
Frontier Capital Management Co. LLC lifted its holdings in Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 2.8% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 597,739 shares of the biotechnolog
Viking Therapeutics, Inc. stock logo
Comerica Bank Reduces Stock Position in Viking Therapeutics, Inc. (NASDAQ:VKTX)
Comerica Bank decreased its holdings in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 69.6% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 60,061 shares of the biotechnology company's stock after
Viking Therapeutics, Inc. stock logo
DAFNA Capital Management LLC Lowers Stock Position in Viking Therapeutics, Inc. (NASDAQ:VKTX)
DAFNA Capital Management LLC trimmed its holdings in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 48.6% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 64,516 shares of the biotec
Viking Therapeutics, Inc. stock logo
Boone Capital Management LLC Boosts Stock Holdings in Viking Therapeutics, Inc. (NASDAQ:VKTX)
Boone Capital Management LLC raised its position in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 8.8% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 209,853 shares of the biotechnology compa
Viking Therapeutics, Inc. stock logo
Viking Therapeutics, Inc. (NASDAQ:VKTX) Position Lifted by Braidwell LP
Braidwell LP grew its stake in Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 27.9% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 1,479,666 shares of the biotechnology company's stock after purchasing an a
Viking Therapeutics, Inc. stock logo
Aptus Capital Advisors LLC Purchases 10,564 Shares of Viking Therapeutics, Inc. (NASDAQ:VKTX)
Aptus Capital Advisors LLC lifted its position in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 27.7% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 48,707 shares of the biotechnology company's st
Viking Therapeutics, Inc. stock logo
Cantor Fitzgerald L. P. Takes $380,000 Position in Viking Therapeutics, Inc. (NASDAQ:VKTX)
Cantor Fitzgerald L. P. bought a new position in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 9,450 shares of the biotechno
Viking Therapeutics, Inc. stock logo
Viking Therapeutics, Inc. (NASDAQ:VKTX) Shares Sold by Bamco Inc. NY
Bamco Inc. NY decreased its position in Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 18.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 385,472 shares of the biotechnology company's stoc
Viking Therapeutics, Inc. stock logo
AQR Capital Management LLC Boosts Holdings in Viking Therapeutics, Inc. (NASDAQ:VKTX)
AQR Capital Management LLC increased its holdings in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 15.9% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 537,239 shares of the biotechnol
Viking Therapeutics, Inc. stock logo
Apis Capital Advisors LLC Has $3.86 Million Stock Position in Viking Therapeutics, Inc. (NASDAQ:VKTX)
Apis Capital Advisors LLC raised its stake in Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 24.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 96,000 shares of the biotechnology company's stock afte
Viking Therapeutics, Inc. stock logo
5AM Venture Management LLC Has $7.63 Million Stock Position in Viking Therapeutics, Inc. (NASDAQ:VKTX)
5AM Venture Management LLC cut its position in Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 20.2% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 189,593 shares of the biot
Viking Therapeutics, Inc. stock logo
683 Capital Management LLC Lowers Holdings in Viking Therapeutics, Inc. (NASDAQ:VKTX)
683 Capital Management LLC reduced its position in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 12.5% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 280,000 shares of the biotechnology comp
Viking Therapeutics, Inc. stock logo
Viking Therapeutics, Inc. (NASDAQ:VKTX) Shares Acquired by MML Investors Services LLC
MML Investors Services LLC increased its holdings in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 45.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 29,673 shares of the biotechnolo
Viking Therapeutics, Inc. stock logo
Research Analysts Set Expectations for VKTX FY2025 Earnings
Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) - Analysts at Cantor Fitzgerald issued their FY2025 earnings per share (EPS) estimates for Viking Therapeutics in a research report issued on Tuesday, April 29th. Cantor Fitzgerald analyst S. Seedhouse forecasts that the biotechnology company
Viking Therapeutics, Inc. stock logo
Viking Therapeutics (NASDAQ:VKTX) Raised to "Strong-Buy" at Cantor Fitzgerald
Cantor Fitzgerald upgraded Viking Therapeutics to a "strong-buy" rating in a report on Tuesday.
Get Viking Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for VKTX and its competitors with MarketBeat's FREE daily newsletter.

VKTX Media Mentions By Week

VKTX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

VKTX
News Sentiment

1.49

1.03

Average
Medical
News Sentiment

VKTX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

VKTX Articles
This Week

7

16

VKTX Articles
Average Week

Get Viking Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for VKTX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:VKTX) was last updated on 5/28/2025 by MarketBeat.com Staff
From Our Partners